FindTrial
Sign In

To study the clinical curative effect of improved Valsalva on patients with vasovagal syncope

To study the clinical curative effect of improved Valsalva on patients with vasovagal syncope

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002514
Enrollment
Unknown
Registered
2012-09-12
Start date
2012-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

syncope

Interventions

1:Routine treatment
2:Routine+modified Valsalva action once a day 50~60 minutes
Healthy control:Nil

Sponsors

Puai Hospital, Huazhong University of Science andTechnology Wuhan, Hubei, CHINA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients are eligible if they have a positive tilt test and3 syncopal spells preceding the tilt test, andif they had no other causes of syncope.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had other causes of syncope, could not give informed consent, had serious diseases or psychopath. Women who were pregnant, ready to pregnant, or breast-feeding a baby were excluded.

Design outcomes

Primary

MeasureTime frame
tilt table test;—

Countries

China

Contacts

Public ContactGu Ye
yegu2003cn@163.com+86 13971010080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026